Cannabis might be a worthy subsitutiion to consider instead if this study is true as benzodiazepines generally carry highier risks of addiction, misuse, and diversion. The goal of this project was to understand the impact of cannabis policy changes on the dispensing of psychotropic medications that are used to treat mental health disorders. The authors focused specifically on the privately insured population, and they investigated changes in dispensing for five categories of medications -- those are benzodiazepines, antidepressants, antipsychotics, barbiturates, and sleep medications. We explored how different types of cannabis policies may have different impacts on our outcomes. We included medical cannabis laws, medical cannabis dispensaries, recreational cannabis laws, and recreational cannabis dispensaries. Prescribing cannabis where state laws allow it, appears to decrease prescription benzodiazepine use. This is a small study and not conclusive, but it points out the possibility that there may be less addictive treatments to mental health ailments with the new cannabis state laws.
A concierge, psychiatric practice offering direct access, quick communication, MD-only care, and minimal wait times for new patients. Serving VA & NC patients - all you need is internet access. Cash only - no insurance - we can generate out of network claim forms.
Text us confidentially anytime at 757-219-2753. Fast response.
Prices: $145 for focused follow-up (15 mins), $175 for 30 mins w/ therapy; $379 for up to 75 min simple intake if there are previous treatment records. New diagnostics and new treatments are longer but reasonably priced. This is a one-stop shop for your ADHD needs.
